| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | -0.22 | 0.07 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | -0.11 | 0.1 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.11 | 0.06 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.4 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.1 | 0.004 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | -0.097 | 0.3 |
| mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | -0.095 | 0.008 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.2 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.093 | 0.2 |
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.004 |